Search Login Register
Extensively Drug-Resistant Tuberculosis
Summary
Description:
Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
Also Known As:
Extremely Drug-Resistant Tuberculosis; Tuberculosis, Extremely Drug-Resistant; XDR-TB; Drug-Resistant Tuberculoses, Extensively; Drug-Resistant Tuberculoses, Extremely Show All >>
Networked: 286
relevant articles (18 outcomes,
31 trials/studies)
for this Disease
Key Drugs and Agents for Extensively Drug-Resistant Tuberculosis
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
linezolid (Zyvox)
:
8 outcomes 11 studies in 52 results
:
FDA 7
-
Thioridazine (Mellaril)
:
3 outcomes 3 studies in 11 results
:
FDA 84
Generic
-
butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)
:
2 outcomes 2 studies in 15 results
: IBA
-
Rifampin (Rifampicin)
:
1 outcome 1 study in 35 results
:
FDA 13
Generic
-
Carbon Monoxide
:
1 outcome 1 study in 30 results
: IBA
-
Anti-Bacterial Agents (Antibiotics)
:
1 outcome 1 study in 15 results
: IBA
-
moxifloxacin (Avelox)
:
1 outcome 1 study in 5 results
:
FDA 8
-
Clofazimine (Lamprene)
:
1 outcome 1 study in 3 results
:
FDA 1
-
Agar
:
1 outcome 1 study in 3 results
: IBA
-
Oxazolidinones (2 Oxazolidone)
:
1 outcome 1 study in 1 result
: IBA
Show All >>
Diseases Related to Extensively Drug-Resistant Tuberculosis
-
Infection
-
Tuberculosis (Tuberculoses)
-
Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
-
Extensively Drug-Resistant Tuberculosis
-
Communicable Diseases (Infectious Diseases)
Show All >>
Key Therapies for Extensively Drug-Resistant Tuberculosis
Efficacy Chart >>
-
Drug Therapy (Chemotherapy)
:
2 outcomes in 13 results
-
Therapeutics
:
1 outcome 2 studies in 5 results
-
Salvage Therapy
:
1 outcome in 1 result
-
Injections
:
51 results
-
Directly Observed Therapy
:
4 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.